Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2004

Feb 11, 2004

34519_dirs_2004-02-11_f9b52357-526f-46e3-8a7d-6cc9be20c882.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2004-02-09

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-02-09 Common Stock, par value $0.10 per share P 500 $4.34 Acquired 355760 Direct
2004-02-09 Common Stock, par value $0.10 per share P 600 $4.39 Acquired 356360 Direct
2004-02-09 Common Stock, par value $0.10 per share P 800 $4.40 Acquired 357160 Direct
2004-02-10 Common Stock, par value $0.10 per share P 500 $4.03 Acquired 357660 Direct
2004-02-10 Common Stock, par value $0.10 per share P 500 $4.00 Acquired 358160 Direct
2004-02-10 Common Stock, par value $0.10 per share P 400 $4.03 Acquired 358560 Direct
2004-02-11 Common Stock, par value $0.10 per share P 500 $4.12 Acquired 359060 Direct
2004-02-11 Common Stock, par value $0.10 per share P 1600 $4.11 Acquired 360660 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.